Home-based Exercice Therapy for Patients With Intermittent Claudication Using a New Smartphone Application
Launched by CHU DE REIMS · Jul 11, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a new smartphone application called E-REVA® to help patients with intermittent claudication, a condition that causes pain in the legs while walking due to reduced blood flow. The app is designed to support patients in their walking rehabilitation by tracking their walking activity, including when pain occurs, how far they can walk, and how long it takes to recover after pain. The goal is to make it easier for patients to manage their condition at home and provide their doctors with useful information to give personalized advice during follow-ups.
To participate in this study, individuals must be over 18 years old and have experienced claudication for more than three months, among other health criteria. Participants can expect to use the E-REVA® app to monitor their walking and pain, and they will be compared to others who do not use the app. This innovative approach aims to improve access to rehabilitation for patients who may not have easy access to specialized centers, ultimately enhancing their quality of life and walking ability.
Gender
ALL
Eligibility criteria
- inclusion criteria :
- • - Patient over 18 years old
- • Patient with claudication on PAD for more than 3 months
- • IPS (systolic pressure index) less than 0.90 at the level of the diseased limb
- • Absence of pathology limiting walk other than PAD
- • Patient having benefited from an arterial ultrasound of the lower limbs demonstrating arterial lesion
- • Absence of myocardial infarction over the last 6 months
- • Absence of cardiac pathology requiring surgery
- • Absence of angina
- • Patient affiliated or entitled to a social security system
- • Patient having given his free and written consent
- exclusion criteria :
- • Patient who has not benefited from an arterial ultrasound of the lower limbs
- * All contraindications to treadmill events:
- • Myocardial infarction within the last 6 months
- • angina
- • Symptomatic tight aortic valve stenosis
- • Pathology limiting walk other than PAD
About Chu De Reims
Chu de Reims, or the University Hospital of Reims, is a leading healthcare institution in France dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent clinical trial sponsor, Chu de Reims focuses on a wide range of therapeutic areas, fostering collaboration between multidisciplinary teams of healthcare professionals and researchers. The hospital is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring that all trials are designed to deliver reliable data while prioritizing patient safety and well-being. Through its robust research infrastructure, Chu de Reims aims to contribute significantly to the advancement of medical knowledge and the development of new treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reims, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials